Vaccine News and Research

Latest Vaccine News and Research

First licensed vaccine could reduce burden in regions with high-levels of dengue infection

The first licensed vaccine for the potentially life-threatening dengue virus should only be used in moderate-to high impacted regions, new research has predicted.

30 Nov 2016

Zika virus can cause glaucoma in infants, report reveals

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

30 Nov 2016

Researchers come up with new approach to stabilize vaccines at room temperature

Shipping vaccines in an unbroken temperature-controlled supply chain (a "cold chain") all the way to recipients is a major logistical and financial challenge in remote areas and developing countries.

30 Nov 2016

Study explores perceptions of college-age males about HPV

Maggie Pitts took great interest in the human papillomavirus vaccine after Virginia became the first state in the country to mandate its use among girls in the sixth grade.

29 Nov 2016

CNIC study characterizes key signal that impedes intercellular communication

A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III, led by Prof. Francisco Sánchez-Madrid, has characterized a cell signal that impedes intercellular communication and could play a central role in biomedical strategies such as gene therapy, vaccine design, and immunotherapy.

29 Nov 2016

Researchers find new way to target deadly virus and develop vaccines

Venezuelan equine encephalitis virus (VEEV) is an unforgiving killer of horses, donkeys and zebras, resulting in mortality as high as 80 percent of infected animals. It causes rapid, catastrophic swelling of the brain and spinal cord, leading to severe neurological symptoms and--in many cases--sudden death.

29 Nov 2016

Study finds no link between infant’s ASD risk and influenza infection during pregnancy

A study of more than 196,000 children found no association between a mother having an influenza infection anytime during pregnancy and an increased risk of autism spectrum disorders (ASDs) in children, according to a new study published online by JAMA Pediatrics.

28 Nov 2016

NIH-supported first HIV vaccine efficacy study begins in South Africa

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.

28 Nov 2016

Mouth cancer rates increase by 68% in the UK over last two decades

A NEW Cancer Research UK analysis reveals that rates of mouth (oral) cancer have jumped by 68 per cent in the UK over the last 20 years, today (Friday).

24 Nov 2016

New vaccine shows potential to decrease risk of fatal opioid overdose

Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone and hydrocodone in animal models.

23 Nov 2016

Pregnant women at risk of infection do not receive flu vaccination, UBC study finds

Health-care professionals are hesitant to administer the flu vaccine to pregnant women, despite the potential life-saving benefits, according to a UBC study.

22 Nov 2016

Study highlights potential to develop antiviral therapies, vaccines for treating astroviruses

Human astroviruses infect nearly everyone during childhood, causing diarrhea, vomiting, and fever.

22 Nov 2016

Researchers make significant progress in developing frontline protection against HIV infection

Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.

22 Nov 2016

Researchers sequence genome of parasitic worm that causes river blindness

Scientists have sequenced the genome of the parasitic worm responsible for causing onchocerciasis--an eye and skin infection more commonly known as river blindness.

21 Nov 2016

WHO confirms pilot deployment of first-generation malaria vaccine in sub-Saharan Africa

The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due to begin in 2018.

21 Nov 2016

Researchers create new Zika replicon system to find ways to combat virus

New research from The University of Texas Medical Branch in Galveston, in collaboration with Southwest University in Chongqing, China and the University of Leuven in Belgium, have developed a way to replicate the basic structure of the Zika virus, stripping it of the genes that make the virus infectious.

18 Nov 2016

ACAAI offers tips for bringing holiday flair, not allergic flares

Holiday decorations are starting to appear, reminding us that Thanksgiving, Hanukkah, Kwanza and Christmas will soon be upon us.

18 Nov 2016

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

NYU Langone Medical Center will lead a five-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and permanently affect the eye.

17 Nov 2016

West Nile virus may cause delayed fatalities long after recovery, new study finds

West Nile virus may be much more deadly than previously believed, with deaths attributable to the mosquito-borne disease occurring not just in the immediate aftermath of the infection but also years later, long after patients seem to have recovered from the initial illness, according to a new study presented today at the 2016 Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)

16 Nov 2016

Portland State University wins Grand Challenges Explorations grant

Portland State University announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

16 Nov 2016